NextCODE helps ANZAC Research Institute bring whole-genome sequencing into clinical care

/0 Comments/in , , , , /by

CAMBRIDGE, Mass.– NextCODE Health today announced that a team at the ANZAC Research Institute in Sydney, Australia have used NextCODE capabilities to home in on novel sequence variants underlying X-linked Charcot-Marie-Tooth syndrome (CMTX). CMTX is a rare and progressively debilitating neurodegenerative disorder. It tends to manifest itself in childhood and can be caused by mutations […]

Read more →

Pacific Biosciences and GenDx Initiate Co-Marketing Activities for Full-Length HLA Gene Sequencing Products

/0 Comments/in , /by

UTRECHT, The Netherlands and MENLO PARK, Calif.– Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II DNA Sequencing System, and GenDx, a pioneer in the area of sequence-based typing and next-generation sequencing for HLA typing, today announced a co-marketing agreement to offer products for full-length HLA gene sequencing. The Human Leukocyte Antigen […]

Read more →

Cepheid And Leading Pharmaceutical Companies Partner On A Diagnostic Test To Help Tackle Multidrug-Resistant Bacterial Infections

/0 Comments/in , /by

SUNNYVALE, Calif. — Cepheid (Nasdaq: CPHD) today announced a new collaboration with AstraZeneca, Cubist Pharmaceuticals, Inc., and GSK intended to promote transformational change in infectious disease therapy by developing a rapid diagnostic test that can target multi-drug resistant pathogens and support the appropriate use of antibiotics. Targeting bacterial infections with the right treatment will slow […]

Read more →

QIAGEN receives FDA approval of artus® CMV RGQ MDx Kit to monitor cytomegalovirus (CMV) viral load in organ transplant patients

/0 Comments/in , /by

GERMANTOWN, Maryland, and HILDEN, Germany -— QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its artus® CMV RGQ MDx Kit for human cytomegalovirus (CMV) has been approved by the U.S. Food and Drug Administration (FDA) under a full premarket approval (PMA). The test is the only FDA-approved PCR-based assay optimized for low- […]

Read more →

OXFORD BIOMEDICAL RESEARCH CENTRE SIGNS CONTRACT WITH GENALICE FOR ITS BREAKTHROUGH SEQUENCED DNA DATA PROCESSING SOLUTION

/0 Comments/in , , , , /by

GENALICE today announced that the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre’s Molecular Diagnostics Centre has signed a contract for a larger model of the GENALICE VAULT, GENALICE’s Next-Generation Sequencing (NGS) data processing appliance. This all-in-one bioinformatics appliance is preloaded with the ultra-fast and highly accurate NGS data processing software, GENALICE MAP. […]

Read more →

Bio-Rad Launches the First Fully-Automated 5th Generation HIV Test

/0 Comments/in , /by

Hercules, CA — — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of its BioPlex® 2200 HIV Ag-Ab kit, the company’s 5th generation HIV test for markets outside the U.S. Similar to 4th generation assays, the BioPlex 2200 HIV […]

Read more →

BD Signs Agreement for Installation of the BD Cato™ Workflow Solution in Leading Cancer Center First Healthcare Institution in the U.S. to Implement the System

/0 Comments/in , /by

FRANKLIN LAKES, N.J.– BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement with The University of Texas MD Anderson Cancer Center for BD Cato™, a system that enhances safety and workflow efficiency in medication preparation via gravimetric and barcoding technology. MD Anderson […]

Read more →

Fluxion Biosciences Announces Collaboration with Stanford University School of Medicine for New Circulating Cancer Biomarkers

/0 Comments/in , , , , /by

SOUTH SAN FRANCISCO, Calif. — Fluxion Biosciences, Inc. announced today that it has initiated a collaboration with the Stanford University School of Medicine focused on developing tests to help deliver more effective therapies to cancer patients. The laboratory of Dr. James Brooks is utilizing Fluxion’s IsoFlux System to isolate, recover, and analyze rare circulating cancer […]

Read more →

Bruker Announces Powerful New Mass Spectrometry Systems and Solutions for Life-Science Research, Clinical Research, Biopharma and Applied Markets

/0 Comments/in , , , , , /by

BALTIMORE — At the 62nd ASMS Conference on Mass Spectrometry and Allied Topics today, Bruker Corporation (NASDAQ:BRKR) today announced mass spectrometry-based product introductions for life-science research and proteomics, for clinical research, for pharma/biopharma/CRO customers, as well as for applied and industrial markets. The new systems and solutions are designed to deliver confident analyses with significantly […]

Read more →